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Abstract
Nasal carriage of Staphylococcus aureus has long been hypothesized to be a major vector for the transmission of virulent
strains throughout the community. To address this hypothesis, we have analyzed the relatedness between a cohort of nasal
carriage strains and clinical isolates to understand better the genetic conformity therein. To assess the relatedness between
nasal carriage and clinical isolates of S. aureus, a genetic association study was conducted using multilocus sequence typing
(MLST) and typing of the hypervariable regions of clumping factor and fibronectin binding protein genes. At all loci
analyzed, genetic associations between both nasal carriage and clinical isolates were observed. Computational analyses of
MLST data indicate that nasal carriage and clinical isolates belong to the same genetic clusters (clades), despite differences
in sequence type assignments. Genetic analyses of the hypervariable regions from the clumping factor and fibronectin
binding protein genes revealed that not only do clinically relevant strains belong to identical genetic lineages as the nasal
carriage isolates within our cohort, but they also exhibit 100% sequence similarity within these regions. The findings of this
report indicate that strains of S. aureus being carried asymptomatically throughout the community via nasal colonization are
genetically related to those responsible for high levels of morbidity and mortality.
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Introduction
Staphylococcus aureus is a prevalent human pathogen of increasing
concern to public health worldwide. This pathogen is one of the
leading causes of hospital-acquired infection, and additionally
leads to significant levels of infection via community transmission.
Approximately 20–30% of the global population is persistently
colonized with S. aureus in the anterior nares, with 60–100% of
individuals projected to be transiently colonized at some point
during their lives [1]. Though nasal carriage of S. aureus is
hypothesized to be a major vector for transmission throughout
hospitals and the community, neither the determinants of nasal
colonization nor the role of carriage in the propagation of S. aureus
infection throughout these settings are well established [2].
Multiple studies have shown that nasal carriage of S. aureus is
a risk factor for pathogenic infection [3,4], but just recently was
it observed that heightened risk is only evident in persistent
nasal carriers whereas intermittent and non-carriers exhibit low
levels of infection [1]. Aside from straightforward incidences in
which endogenous strains establish pathogenic infections in
their hosts, the overall extent to which nasal carriage strains
are responsible for transmissible infection is not currently
known.
Population structure and genetic diversity of S. aureus has been
extensively studied in the past using pulse-field gel electrophoresis
(PFGE) and multilocus sequence typing (MLST) [5,6,7,8,9,10].
While PFGE provides adequate strain resolution, it encounters
difficulty in reproducing and comparing data between laborato-
ries. Thus, MLST is the primary means by which S. aureus strains
have been analyzed for the past decade. Yet, because of the slow
rate of molecular evolution within MLST genes, this methodology
is most useful on a global epidemiology scale [6,11,12]. When local
investigations are carried out, where a greater level of strain
resolution is desired (e.g. local applications such as patient to
patient transmission), analyses of hypervariable virulence genes is
required [13]. Moreover, recent interest in sub-classifying
sequence types (STs) has also identified virulence genes (e.g.
clumping factor and fibronectin binding protein gene families) as
appropriate targets for obtaining high levels of strain resolution
[6,7]. In addition to their hypervariability, virulence genes are also
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these genes contribute to the invasiveness of the bacterium.
Previous studies that have focused on virulence genes have
typically done so in large cohorts of clinical strains where
methodologies such as amplified fragment length polymorphism
typing, spa typing, or double locus sequence typing have been
employed [6,7,11,13,14,15]. Few studies have analyzed virulence
genes to examine S. aureus within the community, or to identify the
genetic relationships between nasal carriage isolates and those
isolated from the clinical setting. Previous studies have identified
that most S. aureus strains, both nasal and clinical, belong to five
major clonal complexes (CCs); CC5, CC8, CC22, CC30, and
CC45 [15]; however, it is not well established whether the genes
responsible for the pathogenicity of S. aureus are genetically similar
between clinical and nasal carriage isolates.
Here we have performed evolutionary analyses on the seven
MLST gene fragments, as well as the hypervariable regions of
virulence genes in a cohort of S. aureus nasal carriage strains to
analyze the genetic diversity present therein. Contrary to previous
reports, we observe higher levels of nucleotide diversity among
nasal carriage strains than those for clinical isolates. In addition to
analyzing the genetic diversity in our cohort of nasal carriage
strains, we also performed a genetic comparison between these
strains and strains of clinical significance. We find that both nasal
carriage strains from our cohort and clinical strains isolated from
symptomatic patients around the world exhibit the same genetic
makeup in housekeeping and virulence genes.
Materials and Methods
Ethics statement for collection of nasal carriage isolates
Nasal carriage isolates of S. aureus were collected from willing
donors following University of Central Florida Institutional
Review Board (IRB)-approved procedures. Written informed
consent was obtained for all donors throughout the study. All
study coordinators involved in the sample collection process were
IRB-approved with Collaborative Institutional Training Initiative
(CITI) certification.
Bacterial isolates
Two hundred and twenty-two healthy individuals at the
University of Central Florida (Orlando, Florida, USA) were
prescreened for the presence of S. aureus in their nares. Of these,
nasal carriage isolates were obtained from 56 (25.2%) individuals
and utilized for genetic analyses in this study. Isolates were collected
by inserting a single cotton swab into each of a donor’s nostrils and
circulating for approximately five to ten seconds. As part of an
ongoing longitudinal study, we obtained multiple samples from
repeat donors, at a minimum interval of one month, to monitor the
population genetics of S. aureus over time. Thus, our data are a
reflection of one representative strain from all individuals involved
in the current study, unless multiple samplings identified different
strains from the same individual. In those cases, all different strains
from one individual were analyzed. Nasal samples were plated on
Trypticase
TM Soy Agar (TSA) containing 5% sheep’s blood
(Becton, Dickinson and Company, Franklin Lakes, New Jersey,
USA), and incubated at 37uC for 16 hours. Bacterial colonies were
identified as S. aureus using Staphyloslide
TM Latex Test reagent
(Becton, Dickinson and Company, Franklin Lakes, New Jersey,
USA), and positive colonies were inoculated in 5 mL of Trypticase
Soy Broth and grown for 16 hours at 37uC and 250 rpm. Following
inoculation, 1.5 mL of bacterial culture was pelleted by centrifu-
gation for two minutes at 16 0006 g and culture medium was
discarded. Pellets were then stored at 280uC until DNA isolation.
Twenty-eight clinical isolates of S. aureus were also utilized in this
study to determine the evolutionary relationships between clinical
strains and strains present in the nasal carriage population. Gene
sequences from 15 clinical isolates with complete genomes
available were obtained from the NCBI nucleotide database
(http://www.ncbi.nlm.nih.gov/nucleotide/). The previously se-
quenced clinical strains were N315, Mu50, COL, MRSA252,
MSSA476, MW2, USA300_FPR3757, NCTC8325, JH1, JH9,
Newman, Mu3, USA300_TCH1516, 04-02981, and TW20
(Table S1). Thirteen additional clinical strains for which clumping
factor A (clfA), clumping factor B (clfB), and fibronectin binding
protein A (fnbA) repeat region sequences are available on the NCBI
nucleotide database were also utilized in this study (Table S1) [13].
Refer to supplemental Table S2 for accession numbers to all DNA
sequences utilized in this study.
DNA isolation/amplification
S. aureus genomic DNA was isolated using GenEluteTM
Bacterial Genomic DNA kit (Sigma-Aldrich Co., St. Louis,
Missouri, USA), according to the manufacturer’s instructions.
Following DNA isolation, extracts were quantified and stored at
220uC until DNA amplification.
Amplification of multilocus sequence typing (MLST) gene
fragments was carried out using primers and protocols described
previously [10]. Briefly, 402–516 bp fragments for the seven
MLST housekeeping genes (arcC, aroE, glpF, gmk, pta, tpi, and yqiL)
were amplified and sequenced (see below). Sequence types (STs)
were determined for each strain based on the alleles identified at
each of the seven loci using the S. aureus MLST database (http://
www.mlst.net) (Table S1). For instances in which new alleles, or
combinations of alleles (i.e. new STs), were identified the MLST
database curator was contacted and new allele numbers and STs
were obtained.
For clfA, clfB, fnbA, and fnbB, the repeat-containing regions were
chosen for molecular analysis within this study. Chromosomal
DNA was amplified using primers and protocols previously
described by Gomes et al. [6]. All primers utilized in this study
were synthesized by Integrated DNA Technologies, Inc. (Coral-
ville, Iowa, USA). For PCR amplification, approximately 20–
30 ng of template DNA was added to a 100 mL reaction
containing 0.02 U/mL of PlatinumH Taq DNA polymerase High
Fidelity (Invitrogen Corporation, Carlsbad, California, USA), 1X
PCR buffer (60 mM Tris-SO4 (pH 8.0), 18 mM ammonium
sulfate), 2 mM MgSO4, 0.3 mM dNTPs, 0.3 mM of each primer,
and 2% (v/v) dimethyl sulfoxide. PCR was conducted using an
iCyclerTM thermal cycler (Bio-Rad Laboratories, Hercules,
California, USA) with the following cycling parameters: 1 cycle
of 5 min. at 95uC; 40 cycles of 30 sec. at 94uC, 60 sec. at
annealing temperature [6,10], 60 sec. at 72uC; 1 cycle of 10 min.
at 72uC; hold at 4uC.
DNA sequencing
Following DNA amplification, PCR products were purified
using isopropanol precipitation and subjected to Sanger sequenc-
ing [16] at The Florida State University DNA Sequencing Facility
(Tallahassee, Florida, USA). Forward and reverse reads were
generated for all amplicons and analyzed using BioEdit Sequence
Alignment Editor [17] and MEGA 4.1 [18]. While the use of these
sequence analysis programs was sufficient for the fnb genes,
additional DNA analysis tools were developed for the clf genes.
Sequence analysis of clf genes
To analyze the highly variable serine-aspartic acid (SD) repeat
region of clfA and clfB, we developed sequence analysis software
Nasal Carriage of Clinically Infectious S. aureus
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analyzes a series of either clfA or clfB DNA sequences, beginning
SD repeat profiling at the TCN-GAY (where N is any nucleotide
and Y is either of the pyrimidines) in the first occurrence of GAT-
TCN-GAY. The program then analyzes tandemly repeating
blocks of 18 nucleotides (one repeat unit) unless nucleotides 13 to
15 are of the sequence TCN, in which case DNA strand-slippage
had occurred and the previous 12 nucleotides are considered as
one shortened repeat. Each unique repeat unit is then assigned a
number, effectively converting the DNA sequence into a numeric
profile. As described in [7], the analysis of clfB was terminated with
the nucleotide immediately prior to the first occurrence of TCN-
GAT-TCA-AGA. For clfA, this is the first time such a program has
been used in profiling the SD repeats, hence no prior termination
sequence has previously been reported. Clumping factor A does
not contain the same terminating sequence as clfB, and therefore,
the program was modified to terminate the analysis with the
nucleotide immediately prior to the first occurrence of TCN-AAC-
AAT-AAT. Refer to supplemental Text files S1 and S2 for the
source code to both, clfA and clfB (respectively), SD repeat profiling
programs.
Using this program, genes of interest were converted to a
numeric profile based on the nucleotide sequence of each
repeating unit, as well as the order and number of repeats.
Therefore, two samples that share identical repeat profiles also
share 100% nucleotide identity. The program assigns numbers to
unique repeat sequences as they are encountered throughout the
dataset, and as such, no inference can be made as to the percent
nucleotide similarity between two different repeat numbers (e.g.
repeat number one is not necessarily more similar to repeat
number two than any other repeat number).
Following the generation of numeric clf repeat profiles, an
additional program was generated to transform the numeric
outputs to color-coded representations. As input, the plotting
software uses the numeric clf repeat profiles along with a file
containing hexadecimal color codes. All repeat units were assigned
a uniquely colored box; therefore, all like-colored boxes are 100%
identical in nucleotide sequence. Refer to supplemental Text file
S3 for the source code to the graphing software utilized in this
study.
Phylogenetic reconstruction of MLST data
To determine the genetic relationship between nasal carriage
isolates and those isolates of clinical origin, phylogenetic analyses
of the concatenated MLST data were carried out for all isolates
analyzed in this study using the Metropolis-Hastings coupled
Markov chain Monte Carlo method (BI) in MrBayes v3.1.2
[19,20]. The concatenated MLST dataset was partitioned by locus
with the nucleotide substitution model for each being determined
using the Akaike Information Criterion (AIC) within jModelTest
v0.1.1 [21,22]. For loci arcC, glpF, pta, and yqiL the K80
substitution model [23] was used. For locus gmk, the K80 plus
Gamma substitution model was employed where Gamma
indicates that, in addition to the substitution matrix determined
by the model for specific nucleotide pairs, a gamma distribution
was also applied to determine the overall substitution rate at each
nucleotide site [24]. For loci aroE and tpi, the SYM [25] plus
Gamma substitution model was used in BI runs. Two independent
BI runs were carried out using random starting trees with one cold
chain and three heated chains. Each run consisted of 5 million
generations with every 100 steps being sampled. As verified using
Tracer v1.5 [26], stationarity was reached after 500 000
generations and a conservative burn-in of 1.25 million (25%)
generations was performed.
Computational analyses of MLST data
Sequence types were assigned to groups using the eBURST v3
program [27] where all members of a group share six of seven
identical loci with at least one other member of the group. Using
eBURST to compare nasal carriage strains to clinical isolates,
nasal carriage strains were treated as the reference set while
clinical isolates were treated as the query set. To identify further
relationships between isolates, a minimal spanning network of
MLST data was generated using TCS v2.1 [28].
Statistical analyses of gene variability and evolution
Nucleotide diversities were determined for aligned DNA
sequences using DnaSP v5 [29]. Molecular evolutionary analyses,
including codon-based Z-tests and dN/dS ratios, were conducted
using MEGA 4.1 [18] under the Nei-Gojobori P-distance method
[30] using 1 000 bootstrap replicates. Indices of discrimination
were calculated for all loci using the Discriminatory Power
Calculator (http://biophp.org/stats/discriminatory_power/demo.
php), which is a modification of the Simpson’s index of
discrimination test [31,32].
Results
Multilocus sequence typing reveals genetic associations
between nasal carriage and clinical isolates
Multilocus sequence typing (MLST) of all 93 S. aureus strains
analyzed in this study identified 34 different sequence types (STs).
Among the 66 nasal carriage isolates, 26 different STs were
observed, four of which were new. Additionally, three new alleles
were also identified by this study, all at locus tpi.
Within the cohort of nasal carriage strains analyzed herein,
ST30 was most prevalent, accounting for ,29% of all isolates.
Sequence types 5 and 8 were also prevalent among the nasal
carriage strains analyzed within this study, together accounting for
,20% of all isolates tested (Table S1). While none of the clinical
isolates analyzed in this study are of ST30, a combined ,32%
belong to ST5 and ST8. The observation of nasal carriage and
clinical isolates belonging to ST5 and ST8 is in agreement with
previous reports in which both nasal carriage and clinical isolates
belong to these same major clusters [9,15,27]. Interestingly, at the
ST level, over half of the clinical isolates analyzed in this study
(,54%) belonged to STs (such as ST105 and ST239) that do not
contain nasal carriage strains (Table S1). However, phylogenetic
analyses of concatenated STs of all strains in this study revealed a
close relationship among both nasal carriage and clinical isolates of
S. aureus (Figure 1). As can be seen in Figure 1, the vast majority of
clades containing clinical isolates (strain names in red text) also
contain nasal carriage strains from the cohort analyzed in this
study (strain names in black text).
In addition to estimating phylogenetic relationships among
strains we also utilized eBurst, which grouped the strains into nine
clusters and eight singletons (Figure 2A). As with the BI, eBURST
identified a high degree of relatedness between nasal carriage and
clinical isolates. While only four STs contain both nasal carriage
and clinical isolates, six of the major clusters contain both classes of
isolates. eBURST groupings were based on strains sharing six of
seven identical loci and takes into consideration the possibility for
genetic recombination; therefore, the level of nucleotide diver-
gence between two different STs contained within the same
genetic cluster cannot be determined. To identify whether large-
scale nucleotide differences were present between isolates grouped
in the same cluster, but belonging to different STs, a minimal
spanning network was generated (Figure 2B). This methodology
does not take recombination events into consideration, but
Nasal Carriage of Clinically Infectious S. aureus
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spanning network revealed that many of the strains clustered by
eBURST and BI contained only one or few polymorphisms
between one another and may further indicate the clonality of the
S. aureus genome. Collectively, all three computational approaches
employed to identify strain relatedness were highly concordant in
revealing the genetic associations between nasal carriage strains
belonging to the cohort generated for this study and clinical
isolates from around the world.
Virulence gene typing facilitates sub-sequence type
strain resolution
Since MLST is based on the analysis of slowly evolving
housekeeping genes within the S. aureus genome, we also analyzed
hypervariable virulence-related genes to characterize further the
genetic relationships between nasal carriage and clinical isolates.
Virulence loci within clf and fnb gene families were chosen because
they have previously been shown to facilitate strain resolution
beyond that which is achievable using MLST alone [6,7]. The
genetic diversity of S. aureus nasal carriage strains was assessed at
clfA, clfB, fnbA, and fnbB. Between 52 (clfA) and 63 (fnbA) different
isolates were typed over the hypervariable repeat regions of the clf
and fnb genes (Figure 3), facilitating additional sub-ST strain
resolution for 16 out of the 66 (,24%) nasal carriage isolates that
underwent MLST (Table S1). As summarized in Table 1, the clf
genes were more variable than the fnb genes, although both gene
families exhibited high levels of genetic diversity, overall. Both clf
genes exhibited indices of discrimination (ID) of approximately
98.5%. Within the fnb loci, both fnbA and fnbB were highly
variable; however, fnbA was slightly more variable than fnbB. With
the exception of clfB, increased IDs were observed in this study as
compared to those previously reported for epidemic strains of S.
aureus where the IDs for clfA, fnbA, and fnbB were found to be
87.5%, 62.8%, and 67.9%, respectively [6]. The elevated IDs
observed here may, in part, be owed to the larger sample size
analyzed within the current study. When epidemic strains were
included in the analysis with nasal carriage strains, the IDs for all
four genes remained relatively unaffected, albeit slightly lower
than with nasal carriage strains alone (Table 1).
Virulence genes in S. aureus provide evidence of
purifying selection despite heightened nucleotide
diversity
Among the virulence genes analyzed in this study, overall
nucleotide diversities were relatively high, with the clf genes
exhibiting approximately three times more nucleotide diversity
than the fnb genes (data not shown). Nucleotide diversities
represent the average number of nucleotide differences between
two sequences at a given site. The nucleotide diversities for clf
genes were approximately 0.15 while those for the fnb genes were
approximately 0.05 (data not shown). Despite high nucleotide
variability across all loci, strong purifying selection was observed
(Table 1) by dN/dS ratios of less than 0.1 at both clf loci. Similarly,
fnb genes exhibited evidence of strong purifying selection (dN/dS
# 0.2) despite their heightened nucleotide diversity. These findings
suggest that the repeat domains within the virulence genes exhibit
a specific and essential function, such that natural selection
maintains amino acid homology in spite of high levels of
nucleotide substitution.
Virulence gene repeat domain lengths are identical
between nasal carriage and clinical isolates
The R regions of the clf genes have previously been assumed to
function as a stalk for the extension of the ligand binding domain
from the bacterial cell wall [33]. Thus, longer R region lengths
may enhance bacterial adherence to nasal epithelia. Since the
repeat region of the wall-spanning domain (Wr) within fnb genes
may also serve a similar function, we extended this hypothesis to
include these domains as well. As such, we aimed to elucidate
whether longer repeat regions associated with nasal carriage
strains as compared to clinical strains of S. aureus.
Collectively, a large degree of length variability was observed
among both nasal carriage strains of S. aureus, as well as clinical
strains. For nasal carriage strains, clf R region lengths ranged from
816 bp to 1212 bp for clfA and 417 bp to 981 bp for clfB. Clinical
strains analyzed in this study exhibited very similar (and often
identical) R region lengths to those of the nasal carrier strains
(Figure 4A). Repeat region lengths within clinical strains of S.
aureus ranged from 666 bp to 1224 bp for clfA and 615 bp to
939 bp for clfB.
When considering the degrees of DNA strand-slippage at each
clf locus, slippage events were three to four times more prevalent in
clfA than clfB. Of 178 unique repeats observed in nasal carriage
strains at clfA, 32 (18%) were 12 nucleotides in length. Of 107
unique repeats observed at clfB, only five (4.7%) were 12
nucleotides in length. When all strains analyzed in this study
(nasal carriage and clinical) were included in repeat profiling, a
total of 185 unique repeats were observed at locus clfA with 34
(18.4%) of these being the result of slippage. When all strains were
included in the analysis of clfB, at total of 109 unique repeats were
observed with six (5.5%) being the result of slippage events (refer to
supplemental Tables S3 and S4).
When analyzing the nucleotide sequences of the fnb genes, the
majority of variation laid within the Wr domains in the form of
indels, resulting in length differences. No difference was observed
in total length of the Wr domains between nasal carriage and
clinical isolates (Figure 4B). At fnbA, Wr domain lengths ranged
from 345 bp to 471 bp for nasal carriage isolates and 273 bp and
429 bp for clinical isolates. At fnbB, Wr domain lengths for nasal
carriage isolates ranged from 273 bp to 378 bp while clinical
isolates ranged from 303 bp and 345 bp. Based on the analysis of
repeat domain lengths alone at clf and fnb loci, it was not possible
to distinguish between nasal carriage and clinical strains of S.
aureus. As such, an analysis of nucleotide sequences was carried out
to determine if, at the nucleotide level, nasal carriage and clinical
strains belong to the same genetic lineages, or if distinct
populations were evident.
Nasal carriage and clinical isolates of S. aureus belong to
the same genetic lineages
To identify relatedness between nasal carriage and clinical
isolates of S. aureus, clf and fnb nucleotide sequences were analyzed.
Collectively, a large degree of nucleotide sequence diversity among
the carrier strains present within our cohort was observed for the
Figure 1. MLST analysis reveals phylogenetic relationships between S. aureus nasal carriage and clinical strains. Bayesian phylogram
indicating the evolutionary relationships of S. aureus strains analyzed in this study. Represented are 66 nasal carriage strains (strains colored in black)
and 27 clinical strains (strains colored in red). Note that several clinical isolates cluster on the same genetic clade as major clinical strains. Numbers
represent posterior probabilities and grey-filled circles represent nodes receiving 100% posterior probability support. Colored boxes are consistent
with strain groupings in Figure 2 (below).
doi:10.1371/journal.pone.0016426.g001
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strains, those written in red are clinical strains and STs written in green indicate both nasal carriage and clinical isolates are contained within. (A)
eBURST application of MLST data from all isolates analyzed in this study. Numbers represent ST. STs that are linked by a line belong to the same
cluster. Circle sizes are proportional to the number of strains within the ST. (B) Minimal spanning network of MLST data from the same isolates
analyzed in (A). Circles represent STs with the numbers within. Branches represent a single nucleotide change between neighboring STs. Black
squares indicate multiple nucleotide changes between adjoining STs with the number of differences indicated by the adjacent numbers. Like-colored
circles represent STs belonging to the same cluster, as in (A). Non-colored circles are singletons by eBURST analysis.
doi:10.1371/journal.pone.0016426.g002
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each locus (refer to supplemental Tables S3 and S4). For clfA,5 2
nasal carriage isolates were genotyped and 178 unique repeat
sequences were identified. Interestingly, clfB exhibits a similar
index of discrimination to that of clfA (Table 1); however, only 107
unique repeat sequences were identified from 61 isolates. While a
large degree of variability within the clf gene fragments analyzed is
the result of point mutations, insertions or deletions of repetitive
units are the primary means of variability. As such, strain
relatedness cannot be determined using algorithms that rely on
sequence alignment [12]. Therefore, in agreement with previous
studies [7,11,12,34,35,36], lineage assignments were carried out by
visual inspection of R domain profiles. On the basis of R domain
typing, the 52 nasal carriage isolates for clfA were grouped into six
lineages (1–6), and 39 haplotypes (Table S1). Lineage 1 was the
largest within the sample set containing 26 of 52 (50%) nasal
carriage isolates (Figure 5A). Interestingly, 24 of the 28 (85.7%)
clinical isolates analyzed herein also belong to this same lineage,
including the highly prevalent and virulent USA300 and MW2
(USA400) strains.
When performing the same R domain analysis at locus clfB, all
61 nasal carriage strains belonged to 12 lineages (1–12), and 44
different haplotypes (Figure 5B and Table S1). Lineages 2 and 3
contain the most nasal carriage isolates with 17 (27.9%) and 16
(26.2%), respectively. As with clfA, a large proportion of the clinical
isolates analyzed within this study also belong to these two lineages
(including again, USA300). Twenty-two of the 28 (78.6%) clinical
isolates analyzed in this study belonged to lineages 2 and 3.
Seventeen (60.7%) isolates share lineage 2 with nasal carriage
strains while another five (17.9%) belong to lineage 3.
Nucleotide sequence analyses of S. aureus isolates were carried
out using the D, W (Wr and Wc) and M domains of the fnb genes
as well. DNA sequence analysis of these domains at locus fnbA
made it possible to categorize all 63 strains analyzed into four
lineages (1–4) while the 56 strains analyzed at fnbB were separated
into five different lineages (1–5) (Table S1). At both fnb loci, two
separate lineages were identified that contained the majority of
nasal carriage isolates. At fnbA, lineages 1 and 4 contained 73% of
the nasal isolates with 33.3% and 39.7%, respectively (Figure 5C).
At fnbB, lineages 1 and 3 were most prevalent within the data set
(76.8% of nasal isolates) with 46.4% and 30.4%, respectively
(Figure 5D). Within fnbA, a total of 59.2% of clinical strains were
identified as belonging to lineages 1 and 4 (14.8% and 44.4%,
respectively), while 100% of clinical strains, at fnbB, belonged to
the two most prevalent nasal carriage lineages, 1 and 3 (36.4% and
63.6%, respectively). The lineage assignment data for both clf and
fnb genes identify further the genetic relatedness between the nasal
carriage strains analyzed in this study and clinically relevant
isolates of S. aureus. However, to further verify the relatedness we
next sought to determine the prevalence of nasal carriage and
clinical strains of S. aureus exhibiting identical virulence gene
sequences.
Nasal carriage and clinical isolates of S. aureus are
identical in clf and fnb gene sequences
At locus clfA, 11 (39.3%) of the clinical isolates (including
USA300) analyzed exhibited identical nucleotide sequence to
isolates from healthy donors. Refer to Figure 6A for a
representation of the sequence similarities within a subset of the
clinical and nasal carriage isolates analyzed herein. For the
complete clfA data set, refer to supplemental Table S5 and
supplemental Figure S1. At clfB, nine (32.1%) clinical isolates,
including USA300 and MW2, exhibit 100% sequence identity to
nasal carrier strains analyzed in this study. Refer to Figure 6B for a
comparison of R regions from a subset of nasal carrier and clinical
isolates. Refer to supplemental Table S6 and supplemental Figure
S2 for the complete clfB data set.
When considering the D and W domains of the fnb genes, a
large percent of clinical isolates exhibited similar, and in many
cases identical, genetic sequences to the nasal carriage strains. In
Table 1. Diversity indices for virulence genes analyzed in this study.
Locus Regions Analyzed
Includes clinical
strains?
# of different
strains
# of different
haplotypes
Index of Discrimination
(ID) (%) dN/dS ratio
clfA R Yes 80 54 98.1 0.0750
No 52 39 98.4 0.0758
clfB R Yes 89 58 98.4 0.0625
No 61 44 98.6 0.0641
fnbA D, W, & M Yes 90 25 89.4 0.2017
No 63 20 92.1 0.1934
fnbB D, W, & M Yes 67 22 90.3 0.1498
No 56 22 91.5 0.1513
doi:10.1371/journal.pone.0016426.t001
Figure 3. Genetic structure of clf and fnb. Double-ended arrows
indicate region of analysis for this study. For clf genes: S, signal sequence;
A, fibrinogen/fibronectin-binding domain; R, serine-aspartic acid repeat
region; W, wall spanning domain; M, membrane spanning domain. For
fnb genes: S, signal sequence; A, fibrinogen-binding domain; B, region
containing 2 repeats of unknown function (only present in fnbA); C,
region containing Du repeats with fibronectin-binding activity; D, region
containing 4–5 repeats with fibronectin-binding activity; Wr, proline-rich
repeat region of the wall spanning domain; Wc, constant region of the
wall spanning domain; M, membrane spanning domain.
doi:10.1371/journal.pone.0016426.g003
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nucleotide sequence identity with nasal carriage isolates. Similarly,
for fnbB, the same was observed for 8 (72.7%) of the clinical
isolates analyzed in this study. Among the clinical strains
exhibiting 100% sequence identity with nasal carriage strains at
fnbA are USA300, N315 and COL (Figure 7). Shown in Figure 7 is
Figure 5. Classification of S. aureus strains reveals lineage associations between nasal carriage and clinical isolates. (A) clfA,N=5 2
nasal carriage and 28 clinical isolates; (B) clfB, N=61 nasal carriage and 28 clinical isolates; (C) fnbA, N=63 nasal carriage and 27 clinical isolates; and
(D) fnbB, N=56 nasal carriage and 11 clinical isolates.
doi:10.1371/journal.pone.0016426.g005
Figure 4. Repeat domain lengths of clf and fnb genes are indistinguishable between nasal carriage and clinical isolates. Shown are
Box and Whisker plots comparing repeat domain lengths between nasal carriage strains of S. aureus and clinical strains. (A) Repeat domain lengths
compared at clf loci; and (B) repeat domain lengths compared at fnb loci.
doi:10.1371/journal.pone.0016426.g004
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study (four nasal carriage and four clinical strains) revealing the
large degree of homology between the two classifications of strains.
At fnbB, USA300 was again observed to exhibit 100% sequence
identity with nasal carriage strains (data not shown), further
supporting the relatedness of nasal carriage strains from the cohort
analyzed in this study and clinical isolates of worldwide origin.
Discussion
Due to the increasing public health concern regarding the
severity and rates of S. aureus infection throughout the world, it was
the goal of this study to perform an evolutionary genetic analysis of
nasal carriage strains of S. aureus from a healthy population while
also analyzing the relatedness of these isolates to strains responsible
Figure 6. Nasal carriage and clinical isolates of S. aureus share (near-)identical clf repeat region sequences. Shown are clf repeat regions
represented as color-coded bars. Like-colored boxes indicate 100% sequence similarity between isolates. (A) clfA and (B) clfB repeat region sequences
from a representative sampling of all isolates analyzed within this study. Isolate names written in black are nasal carriage strains and those writteni n
red are clinical strains.
doi:10.1371/journal.pone.0016426.g006
Figure 7. Comparison of FnbA amino acid sequences between four representative nasal carriage and four representative clinical
S. aureus isolates. Note that identical sequences are evident between both nasal carriage and clinical isolates. D1–D4, repeat region containing
fibronectin-binding activity; Wr1–Wr7, proline-rich repeat region of the wall spanning domain; Wc, constant region of the wall spanning domain.
Isolate names written in black are nasal carriage strains and those written in red are clinical strains. Regions of amino acid variability are shaded grey
and underlined.
doi:10.1371/journal.pone.0016426.g007
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were conducted to determine the relatedness of clinical and nasal
carriage isolates. Bayesian estimation of strain relatedness identified
clades containing both nasal carriage and clinical isolates, indicating
that these two groups share a recent common ancestor. One
drawback to this approach is that, presumably due to the low
variability and slow rate of evolution within housekeeping genes,
low posterior probabilities are observed due to lack of genetic
variability. As such, eBURST and a maximum parsimony
minimum spanning network analyses were carried out. eBURST
takes into consideration the fact that genetic recombination events
within bacterial genomes occur and therefore, highly related strains
may still exhibit large-scale nucleotide variation at one or few loci.
Here, we generated eBURST clusters requiring six of seven
identical loci between strains. Using this method, all of the strains
analyzed in this study (nasal carriage and clinical) were clustered
into few groups, identifying high genetic relatedness between the
nasal carriage strains analyzed in this study and clinical isolates
previously identified from around the world.
While many bacterial genomes exhibit high levels of genetic
recombination, S. aureus has previously been shown to be highly
clonal [9,15], and therefore, a minimal spanning network based on
maximum parsimony analysis was also conducted. Once again, the
MLST data identified that nasal carriage and clinical strains are
genetically related, with only few, if any, single nucleotide
polymorphisms present between groups. Moreover, many of the
sequence types (STs) that were clustered using BI and eBURST
were also identified by this method as being closely related.
Collectively, MLST of nasal carriage and clinical strains in this
study indicates that these strains share common genetic lineages
based on housekeeping gene fragments in the common minimal
genome. This finding unto itself is not surprising given previous
reports of nasal carriage and clinical isolates sharing common
lineages [9,15,27] and that the nature of MLST limits the distinction
between strains, which may in turn over represent the relatedness of
nasal carriage and clinical isolates. To increase discrimination
between strains virulence genes were also analyzed. Not only are
virulence genes attractive because of their suitability for analyzing
smallgeographicregionsandprovidingsub-sequencetype resolution
[6,11,12], but also because of their involvement in the pathogenicity
of S. aureus. Adhesion genes from the clumping factor gene family
(specifically, clfB) are known to play a significant role in nasal
colonization [37] while fibronectin binding protein genes are major
contributors to the virulence of S. aureus in clinical settings [38]. A
number of reports utilized genetic typing of these virulence genes for
their discriminatory capabilities between isolates, particularly those
belonging to the same ST. By contrast, the current study is, to our
knowledge, the first report on the sequence diversity of virulence-
related genes from nasal carriage strains of S. aureus from a cohort of
healthy individuals in the United States.
Here, we have observed a discriminatory power among the
virulence genes superior to that reported previously for only
clinical strains [6]. This discrepancy may, in part, be owed to the
ethnic diversity within our study area, but may also be an
indication of the complex evolutionary processes of S. aureus;
namely the potential for nasal carriage strains to continuously
adapt to new environments and evade the host immune system
(via continual host-to-host transmission). Using the enhanced
discriminatory power of virulence genes, sub-ST strain resolution
was achieved for a large percent (,24%) of strains analyzed in this
study. The heightened discriminatory ability of virulence genes
was attributable to the high degree of genetic variability at these
loci. Interestingly, while a high level of genetic variability was
identified among the clf and fnb loci, a strong indication of
purifying selection was still observed. Purifying selection is a
reflection that, on average, little to no adaptive diversification
(positive selection) of the gene’s protein product is being
maintained in the population [39], thus suggesting a possible role
in the preservation of a specific function.
In order to assess the relatedness of nasal carriage isolates
obtained for this study to clinical isolates, the first analysis
identified length differences within the repeat regions of the clf and
fnb genes. The repeat regions of the clf and fnb genes are highly
variable in their number of repeating units and these regions are
presumed to show the greatest variability between different strains.
Discrimination based on the number of repeat units within these
regions did not facilitate distinction between nasal carriage strains
and clinical isolates. Perhaps the mere presence of determinant
virulence genes is sufficient to confer pathogenicity and is not
necessarily related to any genetic differences within virulence
genes between strains. This hypothesis requires further explora-
tion, as few studies have focused their efforts on the contributions
of different genetic regions to pathogen virulence. Initial support to
this hypothesis is observed with ClfA. Interestingly, the ClfA
protein requires a minimum of 80 amino acid residues within its
repeat domain [40]; below this critical length, reduced ClfA
activity is observed, while no obvious difference in activity is
observed when the length increases. It is possible that the length of
the repeat domains within clfB or fnb genes is sufficient for protein
function and as long as they are greater than an, as yet unknown,
minimum length, protein function and consequential virulence are
indistinguishable between strains.
While differences in repeat length may not directly promote
virulence, they may be important in the ability of a strain to
colonize nasal epithelia. The difference between persistent,
intermittent, or non-carriage may be dependent upon the repeat
domain lengths of adhesion genes. Such a consideration has
previously been addressed for the coagulase and protein A genes,
with no correlation between carriage status and repeat length
identified [41]; however, never before has such a longitudinal
study been conducted for the clf or fnb genes, which were
previously identified as putative determinants of nasal carriage.
Variable number of tandem repeat profiling did not yield clear
distinctions between nasal carriage and clinical isolates, and as
such an analysis of nucleotide sequence variability was subse-
quently carried out for clf and fnb genes. With increasing
frequency, analyses such as this for the clf genes are being
conducted [6,7,42,43,44], and we feel that a database, much like
that for spa typing and MLST, would be beneficial for the transfer
and continuity of R domain data between laboratories. The
software for R region profiling used in this study is publicly
available, and could be combined in a database with all previous
repeat sequences and profiles to facilitate faithful identification of
strains worldwide. The large amount of data being obtained for clf
genes and the observed importance of these genes in the
classification of strains necessitates the transfer and continuity of
genetic data between laboratories. Using the software for clf repeat
region profiling developed in this study and multiple sequence
analysis of fnb genes, the classification of nasal carriage and clinical
isolates into genetic lineages was conducted.
A high proportion of clinical isolates analyzed in this study
(.75%) belonged to the same genetic lineages as nasal carriage
strains, revealing an evolutionary relationship stronger than has
heretofore been identified. That being said, it is recognized that a
full appreciation for the genetic relatedness between nasal carriage
and clinical isolates will require future endeavors with employment
of large scale molecular typing on large cohorts of both nasal
carriage and clinical isolates from the same geographic region. Here
Nasal Carriage of Clinically Infectious S. aureus
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diverse population of clinical strains from around the world has
shown genetic relatedness to strains from a nasal carriage
population. Furthermore, as next generation sequencing becomes
a more feasible option for bacterial typing, and strain collections
become more prevalent, the relatedness of nasal carriage and
clinical isolates will be more easily and reliably identified.
Of particular interest to this study are the molecular similarities
between nasal carriage strains and the highly virulent community-
associated methicillin-resistant (CA-MRSA) strains USA300 and
MW2 (USA400). These are the two most prevalent strains
responsible for CA-MRSA infection within the United States,
responsible for 97–99% of all community-acquired skin and soft
tissue infections [45,46,47]. Interestingly, while USA300 and MW2
do not belong to the same ST, they do share common lineages to
each other at clfA and fnbB (Table S1). They also share common
lineages with many nasal carriage strains at all four virulence genes
analyzed, belonging to the same lineages as the majority of nasal
carriage strains in all cases. Collectively, nucleotide diversities within
the repeat regions of clf and fnb loci facilitate high discriminatory
power between strains; however, the molecular data do not
distinguish the nasal carriage strains belonging to the cohort analyzed
in this study from clinical isolates. In fact, the molecular population
analyses indicate that nasal carrier strains share molecular lineages,
and are often genetically identical to those strains of clinical
significance. While the virulence of a bacterial strain is undoubtedly
multifactorial, involving an as yet unknown number of virulence
genes, not to mention host factors, the genetic associations identified
within this study between clinical and nasal carriage isolates suggest
thatstrainrelatednessbetweennasalcarriageandclinicalisolatesmay
be higher than has previously been recognized.
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Figure S1 Color-coded repeats of clfA R domains. Shown are
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in this study.
(TIF)
Figure S2 Color-coded repeats of clfB R domains. Shown are
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